| Endocrine Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived185 of 185show fewer |
|---|
| → investigated in trials for | Etoposidesmall molecule 148 trials (58 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 132 trials (50 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 132 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 102 trials (33 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 102 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 71 trials (31 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 66 trials (38 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 66 trials (23 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 58 trials (37 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 48 trials (21 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 39 trials (8 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 29 trials (14 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lurbinectedinsmall molecule 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 29 trials (12 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarlatamabmonoclonal antibody 26 trials (23 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 23 trials (11 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 21 trials (7 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 20 trials (15 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 16 trials (5 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 16 trials (8 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 16 trials (10 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 13 trials (9 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rovalpituzumab Tesirineadc 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amrubicinsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 10 trials (3 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitotanesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Oxodotreotideother 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralsetinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sugemalimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Barasertibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linsitinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lucitanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Picoplatinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vatalanibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | 7-Ethyl-10-Hydroxycamptothecinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amuvatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aurora A Kinase Inhibitor LY3295668 Erbumine 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemoimmunotherapy 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daromun 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinutuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lifileucelcell therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Margetuximabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | PD-L1 Inhibitor 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Platinum Compound 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Porfimer 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prexasertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rezatapoptsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rilotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Streptozocinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tarextumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teniposidesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Therapeutic Tumor Infiltrating Lymphocytes 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tovorafenibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Endocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |